Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 4 7Phase 1 5Phase 2 4Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Completed 27Unknown 5Recruiting 5Terminated 4Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 413Carcinoma, Non-Small-Cell Lung 286Prostatic Neoplasms 208Neoplasms 204Neoplasm Metastasis 180Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 158Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 105Carcinoma, Renal Cell 104Brain Neoplasms 90Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 60

Interventions

Sugars 1Metformin 1Linseed Oil 1Clomiphene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Polycystic Ovary Syndrome × Clear all
NCT05370521 2025-10-09

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Spruce Biosciences

Phase 2 Terminated
27 enrolled 18 charts

Adrenal Gland Diseases, Polycystic Ovary Syndrome

NCT02523898 2024-04-25

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Semnan University of Medical Sciences

Phase 2 Terminated
388 enrolled

Infertility, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02865915 2021-02-01

MLE4901 vs. Placebo for the Treatment of PCOS

Millendo Therapeutics, Inc.

Phase 2 Terminated
55 enrolled 10 charts

Acne Vulgaris, Alopecia, Hirsutism, Menstruation Disturbances, Polycystic Ovary Syndrome

NCT00693082 2012-11-20

Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

Duke University

Phase 2 Terminated
4 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡